Gentian Diagnostics ASA (OSL: GENT)
Norway flag Norway · Delayed Price · Currency is NOK
40.00
-0.20 (-0.50%)
Dec 27, 2024, 4:25 PM CET

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 32.70M NOK in the quarter ending September 30, 2024, with 1.96% growth. This brings the company's revenue in the last twelve months to 154.12M, up 19.88% year-over-year. In the year 2023, Gentian Diagnostics ASA had annual revenue of 142.35M with 27.18% growth.

Revenue (ttm)
154.12M
Revenue Growth
+19.88%
P/S Ratio
4.00
Revenue / Employee
2.66M
Employees
58
Market Cap
616.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023142.35M30.42M27.18%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 201955.38M9.56M20.87%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nordhealth AS 513.12M
Medistim ASA 541.82M
Photocure ASA 526.25M
Carasent ASA 264.80M
Nykode Therapeutics AS 46.02M
ArcticZymes Technologies ASA 110.76M
Hofseth BioCare ASA 248.08M
Navamedic ASA 525.55M
Revenue Rankings